
Sep 26, 2026
BioLineRx Files Form F-1 to Register Resale of 2,023,382 ADSs Linked to August 2026 Warrants
BioLineRx Ltd. (NASDAQ:BLRX) has filed a Form F-1 registration statement with the SEC to allow for the resale of up to 2,023,382 American Depositary Shares (ADSs) by a selling shareholder. These ADSs are tied to warrants issued during a private placement in August 2026. BioLineRx will not receive proceeds from this ADS resale, but may gain funds from any cash exercises of the warrants.
Company relevance
100.00%
Company sentiment
Neutral
Overall sentiment
Neutral